RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
182 hedge funds and large institutions have $1.7B invested in Revance Therapeutics, Inc. in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 67 increasing their positions, 40 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
68% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 40
13% more funds holding
Funds holding: 161 → 182 (+21)
Holders
182
Holding in Top 10
4
Calls
$239M
Puts
$90.9M
Top Buyers
| 1 | +$93.4M | |
| 2 | +$28.8M | |
| 3 | +$23.1M | |
| 4 |
Two Sigma Investments
New York
|
+$21M |
| 5 |
JCAM
Jericho Capital Asset Management
New York
|
+$19.3M |
Top Sellers
| 1 | -$36.5M | |
| 2 | -$33.4M | |
| 3 | -$18.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11.9M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$9.96M |